Cibus, Inc. issued a correction regarding the rice gene editing conversion rates previously disclosed in its January 16, 2025, press release. The company concluded that the reported gene editing conversion rates of 10-25% in Rice have not been reconfirmed.
This lack of reconfirmation is attributed to subsequent experiments showing high variability in the conversion rate data. Cibus stated it is continuing to advance its oligonucleotide directed mutagenesis (ODM) editing technologies to improve editing conversion rates across its crops of interest.
Greg Gocal, Chief Scientific Officer, affirmed the company's belief that its standardized high-throughput, semi-automated Rapid Trait Development System (RTDS) will deliver the required edits in customer germplasm with a time-bound and predictable process, despite the observed variability.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.